IP vs XFOR · P/E 43, $26.62B cap vs rev $2.6M
International Paper (IP) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported XFOR revenue for 2024-12-31 was $2.6M. Net income was -$37.5M. XFOR currently screens at market cap $382.0M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the IP and XFOR stock pages for the full models.
Not investment advice.